avapro and deoxyglucose
avapro has been researched along with deoxyglucose in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Henriksen, EJ; Jacob, S; Kinnick, TR; Krekler, M; Teachey, MK | 1 |
Hanssen, NMJ; Hovind, P; Parving, HH; Persson, F; Piazza, M; Rossing, P; Schalkwijk, CG; Scheijen, JL; Stehouwer, CDA; van de Waarenburg, MPH; van Greevenbroek, MMJ | 1 |
Trials
1 trial(s) available for avapro and deoxyglucose
Article | Year |
---|---|
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glyoxal; Humans; Irbesartan; Male; Middle Aged; Pyruvaldehyde; Tandem Mass Spectrometry; Time Factors; Treatment Outcome | 2021 |
Other Studies
1 other study(ies) available for avapro and deoxyglucose
Article | Year |
---|---|
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.
Topics: Angiotensin Receptor Antagonists; Animals; Area Under Curve; Biological Transport; Biphenyl Compounds; Blood Glucose; Body Weight; Deoxyglucose; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Insulin; Insulin Resistance; Irbesartan; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Organ Size; Rats; Rats, Zucker; Tetrazoles | 2001 |